Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +0.52% inched 0.99% higher to $120.61 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.33% rising 0.28% to 4,536.95 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.51% rising 0.37% to 35,443.82. This was the stock's second consecutive day of gains. Edwards Lifesciences Corp. hit a new 52-week high, surpassing its previous peak of $119.94, which the company reached on August 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +0.30% rose 0.42% to $134.73, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +0.83% fell 1.14% to $45.06, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +1.41% rose 1.70% to $203.79. Trading volume (1.9 M) remained 282,660 below its 50-day average volume of 2.2 M.